-
1
-
-
77953857048
-
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: A randomised, double-blind, placebo-controlled trial
-
C.J. Bailey, J.L. Gross, A. Pieters, A. Bastien, and J.F. List Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: A randomised, double-blind, placebo-controlled trial Lancet 375 9733 2010, June 2223 2233
-
(2010)
Lancet
, vol.375
, Issue.9733
, pp. 2223-2233
-
-
Bailey, C.J.1
Gross, J.L.2
Pieters, A.3
Bastien, A.4
List, J.F.5
-
2
-
-
0031888707
-
Treatment of vulvovaginal candidiasis in patients with diabetes
-
N.J. Bohannon Treatment of vulvovaginal candidiasis in patients with diabetes Diabetes Care 21 3 1998, March 451 456
-
(1998)
Diabetes Care
, vol.21
, Issue.3
, pp. 451-456
-
-
Bohannon, N.J.1
-
3
-
-
18744378563
-
Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes
-
E.M. de Leon, S.J. Jacober, J.D. Sobel, and B. Foxman Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes BMC Infectious Diseases 2 2002 1
-
(2002)
BMC Infectious Diseases
, vol.2
, pp. 1
-
-
De Leon, E.M.1
Jacober, S.J.2
Sobel, J.D.3
Foxman, B.4
-
4
-
-
0141955625
-
Lower genital tract infections in diabetic women
-
G.G. Donders Lower genital tract infections in diabetic women Current infectious disease report 4 6 2002, December 536 539
-
(2002)
Current Infectious Disease Report
, vol.4
, Issue.6
, pp. 536-539
-
-
Donders, G.G.1
-
5
-
-
77956921439
-
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
-
E. Ferrannini, S.J. Ramos, A. Salsali, W. Tang, and J.F. List Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial Diabetes Care 33 10 2010, October 2217 2224
-
(2010)
Diabetes Care
, vol.33
, Issue.10
, pp. 2217-2224
-
-
Ferrannini, E.1
Ramos, S.J.2
Salsali, A.3
Tang, W.4
List, J.F.5
-
6
-
-
84859030635
-
SGLT2 inhibitors: A new emerging therapeutic class in the treatment of type 2 diabetes mellitus
-
R.K. Ghosh, S.M. Ghosh, S. Chawla, and S.A. Jasdanwala SGLT2 inhibitors: A new emerging therapeutic class in the treatment of type 2 diabetes mellitus Journal of Clinical Pharmacology 52 4 2012, April 457 463
-
(2012)
Journal of Clinical Pharmacology
, vol.52
, Issue.4
, pp. 457-463
-
-
Ghosh, R.K.1
Ghosh, S.M.2
Chawla, S.3
Jasdanwala, S.A.4
-
7
-
-
0033758731
-
Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status
-
R. Goswami, V. Dadhwal, S. Tejaswi, and K. Datta Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status Journal of Infection 41 2 2000, September 162 166
-
(2000)
Journal of Infection
, vol.41
, Issue.2
, pp. 162-166
-
-
Goswami, R.1
Dadhwal, V.2
Tejaswi, S.3
Datta, K.4
-
8
-
-
48249146624
-
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
-
S. Han, D.L. Hagan, J.R. Taylor, and L. Xin Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats Diabetes 57 6 2008, June 1723 1729
-
(2008)
Diabetes
, vol.57
, Issue.6
, pp. 1723-1729
-
-
Han, S.1
Hagan, D.L.2
Taylor, J.R.3
Xin, L.4
-
9
-
-
84883810898
-
Urinary tract infections in patients with diabetes treated with dapagliflozin
-
K.M. Johnsson, A. Ptaszynska, B. Schmitz, J. Sugg, S.J. Parikh, and J.F. List Urinary tract infections in patients with diabetes treated with dapagliflozin Journal of Diabetes and Its Complications 27 5 2013 473 478
-
(2013)
Journal of Diabetes and Its Complications
, vol.27
, Issue.5
, pp. 473-478
-
-
Johnsson, K.M.1
Ptaszynska, A.2
Schmitz, B.3
Sugg, J.4
Parikh, S.J.5
List, J.F.6
-
10
-
-
65349196064
-
Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
-
J.F. List, V. Woo, E. Morales, W. Tang, and F.T. Fiedorek Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes Diabetes Care 32 4 2009, April 650 657
-
(2009)
Diabetes Care
, vol.32
, Issue.4
, pp. 650-657
-
-
List, J.F.1
Woo, V.2
Morales, E.3
Tang, W.4
Fiedorek, F.T.5
-
11
-
-
41649087328
-
Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
-
W. Meng, B.A. Ellsworth, A.A. Nirschl, and P.J. McCann Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes Journal of Medicinal Chemistry 51 5 2008, March 1145 1149
-
(2008)
Journal of Medicinal Chemistry
, vol.51
, Issue.5
, pp. 1145-1149
-
-
Meng, W.1
Ellsworth, B.A.2
Nirschl, A.A.3
McCann, P.J.4
-
12
-
-
84883830318
-
Characterization of urinary tract infections in the setting of pharmacologically-induced glucosuria
-
S. Parikh, K. Johnsson, A. Ptaszynska, and B. Schmitz Characterization of urinary tract infections in the setting of pharmacologically-induced glucosuria Presented at: 71st Scientific Sessions of the American Diabetes Association, June 24-28, 2011. San Diego, CA 2011
-
(2011)
Presented At: 71st Scientific Sessions of the American Diabetes Association, June 24-28, 2011. San Diego, CA
-
-
Parikh, S.1
Johnsson, K.2
Ptaszynska, A.3
Schmitz, B.4
-
13
-
-
33644688031
-
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes
-
H. Rahmoune, P.W. Thompson, J.M. Ward, C.D. Smith, G. Hong, and J. Brown Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes Diabetes 54 12 2005, December 3427 3434
-
(2005)
Diabetes
, vol.54
, Issue.12
, pp. 3427-3434
-
-
Rahmoune, H.1
Thompson, P.W.2
Ward, J.M.3
Smith, C.D.4
Hong, G.5
Brown, J.6
-
14
-
-
0020061395
-
Infection and diabetes: The case for glucose control
-
E.J. Rayfield, M.J. Ault, G.T. Keusch, M.J. Brothers, C. Nechemias, and H. Smith Infection and diabetes: The case for glucose control American Journal of Medicine 72 3 1982, March 439 450
-
(1982)
American Journal of Medicine
, vol.72
, Issue.3
, pp. 439-450
-
-
Rayfield, E.J.1
Ault, M.J.2
Keusch, G.T.3
Brothers, M.J.4
Nechemias, C.5
Smith, H.6
-
15
-
-
84862875221
-
Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy
-
J. Rosenstock, M. Vico, L. Wei, A. Salsali, and J.F. List Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy Diabetes Care 35 7 2012, July 1473 1478
-
(2012)
Diabetes Care
, vol.35
, Issue.7
, pp. 1473-1478
-
-
Rosenstock, J.1
Vico, M.2
Wei, L.3
Salsali, A.4
List, J.F.5
-
16
-
-
79961083208
-
Kidney in diabetes: From organ damage target to therapeutic target
-
T. Salvatore, O. Carbonara, D. Cozzolino, R. Torella, R. Nasti, and N. Lascar Kidney in diabetes: From organ damage target to therapeutic target Current Drug Metabolism 12 7 2011, April 658 666
-
(2011)
Current Drug Metabolism
, vol.12
, Issue.7
, pp. 658-666
-
-
Salvatore, T.1
Carbonara, O.2
Cozzolino, D.3
Torella, R.4
Nasti, R.5
Lascar, N.6
-
17
-
-
80052524011
-
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: A randomised, 24-week, double-blind, placebo-controlled trial
-
K. Strojek, K.H. Yoon, V. Hruba, M. Elze, A.M. Langkilde, and S. Parikh Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: A randomised, 24-week, double-blind, placebo-controlled trial Diabetes, Obesity & Metabolism 13 10 2011, October 928 938
-
(2011)
Diabetes, Obesity & Metabolism
, vol.13
, Issue.10
, pp. 928-938
-
-
Strojek, K.1
Yoon, K.H.2
Hruba, V.3
Elze, M.4
Langkilde, A.M.5
Parikh, S.6
-
18
-
-
69549095914
-
A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: Applicability of a novel insulin-independent treatment
-
J.P. Wilding, P. Norwood, C. T'joen, A. Bastien, J.F. List, and F.T. Fiedorek A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: Applicability of a novel insulin-independent treatment Diabetes Care 32 9 2009, September 1656 1662
-
(2009)
Diabetes Care
, vol.32
, Issue.9
, pp. 1656-1662
-
-
Wilding, J.P.1
Norwood, P.2
T'Joen, C.3
Bastien, A.4
List, J.F.5
Fiedorek, F.T.6
-
19
-
-
84858323889
-
Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: A randomized trial
-
J.P. Wilding, V. Woo, N.G. Soler, A. Pahor, J. Sugg, and K. Rohwedder Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: A randomized trial Annals of Internal Medicine 156 6 2012, March 405 415
-
(2012)
Annals of Internal Medicine
, vol.156
, Issue.6
, pp. 405-415
-
-
Wilding, J.P.1
Woo, V.2
Soler, N.G.3
Pahor, A.4
Sugg, J.5
Rohwedder, K.6
-
20
-
-
77953181310
-
Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: Effects on glycaemic control and body weight
-
L. Zhang, Y. Feng, J. List, S. Kasichayanula, and M. Pfister Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: Effects on glycaemic control and body weight Diabetes, Obesity & Metabolism 12 6 2010 510 516
-
(2010)
Diabetes, Obesity & Metabolism
, vol.12
, Issue.6
, pp. 510-516
-
-
Zhang, L.1
Feng, Y.2
List, J.3
Kasichayanula, S.4
Pfister, M.5
|